Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia

William G. Wierda, John C. Byrd, Susan O'Brien, Steven Coutre, Paul M. Barr, Richard R. Furman, Thomas J. Kipps, Jan A. Burger, Don A. Stevens, Jeff Sharman, Paolo Ghia, Ian W. Flinn, Cathy Zhou, Joi Ninomoto, Danelle F. James, Constantine S. Tam

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia'. Together they form a unique fingerprint.